...
首页> 外文期刊>FEBS letters. >High expression of long non-coding RNA H19 is required for efficient tumorigenesis induced by Bcr-Abl oncogene
【24h】

High expression of long non-coding RNA H19 is required for efficient tumorigenesis induced by Bcr-Abl oncogene

机译:Bcr-Abl致癌基因有效诱导肿瘤发生需要长的非编码RNA H19的高表达

获取原文
获取原文并翻译 | 示例
           

摘要

Dysregulation of non-coding RNA H19 has been observed in various tumors. However, it remains unknown whether H19 is involved in Bcr-Abl-induced leukemia. Here, we demonstrate a critical requirement for H19 in Bcr-Abl-mediated tumorigenesis. H19 was highly expressed in Bcr-Abl-transformed cell lines and primary cells derived from patients in a Bcr-Abl kinase-dependent manner. Silencing H19 expression sensitized leukemic cells to undergo imatinib-induced apoptosis and inhibited Bcr-Abl-induced tumor growth. Furthermore, H19 was shown to be regulated by c-Myc in Bcr-Abl-expressing cells. These results reveal an important role H19 plays in Bcr-Abl-mediated transformation and provide novel insights into complex mechanisms underlying Bcr-Abl-induced cancers.
机译:在各种肿瘤中已经观察到非编码RNA H19的失调。然而,尚不清楚H19是否参与Bcr-Abl诱导的白血病。在这里,我们证明了Bcr-Abl介导的肿瘤发生中H19的关键要求。 H19以Bcr-Abl激酶依赖性方式在Bcr-Abl转化的细胞系和源自患者的原代细胞中高表达。沉默H19表达使白血病细胞发生伊马替尼诱导的细胞凋亡并抑制Bcr-Abl诱导的肿瘤生长。此外,显示H19在表达Bcr-Abl的细胞中受c-Myc调控。这些结果揭示了H19在Bcr-Abl介导的转化中发挥的重要作用,并为Bcr-Abl诱导的癌症的潜在复杂机制提供了新颖的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号